![Michael Perkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Michael Perkins, MD, is Chief Medical Officer & Development Director at Oxagen Ltd.
Dr. Perkins was previously employed as Chief Development Officer by Ionix Pharmaceuticals Ltd., a Principal by AstraZeneca Plc, and Vice President-Worldwide Regulatory Affairs by Pfizer Ltd.
He received his doctorate degree from the University of Leeds.
| Bedrijven | Functie | Einde |
|---|---|---|
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Algemeen Adviseur | - |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Hoofd Techniek/Wetenschap/O&O | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Ionix Pharmaceuticals Ltd.
 Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops analgesic medicines | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Ionix Pharmaceuticals Ltd.
Ionix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops analgesic medicines | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
